e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Mechanisms and outcomes of infective exacerbations of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metagenomic analysis of lower airway microbial diversity in patients with chronic pulmonary disease
E. Monso, R. Cabrera, A. Moya, A. Mira, M. Garcia, X. Pomares, J. M. Antó (Sabadell, Valencia, Barcelona, Spain)
Source:
Annual Congress 2011 - Mechanisms and outcomes of infective exacerbations of COPD
Session:
Mechanisms and outcomes of infective exacerbations of COPD
Session type:
Oral Presentation
Number:
200
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Monso, R. Cabrera, A. Moya, A. Mira, M. Garcia, X. Pomares, J. M. Antó (Sabadell, Valencia, Barcelona, Spain). Metagenomic analysis of lower airway microbial diversity in patients with chronic pulmonary disease. Eur Respir J 2011; 38: Suppl. 55, 200
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019
Oropharyngeal and sputum microbiome dynamics with the same pattern following exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
Sputum microbiome richness is decreased in patients treated for acute exacerbations of eosinophilic chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Co-occurrence analysis relates a macrolide resistome to the pulmonary microbiome in chronic respiratory disease
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Gut microbiomes in chronic obstructive pulmonary disease
Source: International Congress 2018 – Microbiomes in respiratory disease
Year: 2018
Distal airways bacterial colonization and inflammatory pattern in children with different chronic lung diseases: A bronchoscopic study
Source: Annual Congress 2010 - Fibre-optic bronchoscopy and bronchoalveolar lavage in the treatment of paediatric respiratory diseases
Year: 2010
History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 566s
Year: 2003
The lower airways microbiome in patients with IPF and COPD
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
Biomarker discovery in chronic obstructive pulmonary disease (COPD) using epithelial lining fluid: A proteomic approach
Source: Annual Congress 2011 - Phenotyping airway diseases
Year: 2011
Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease
Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016
Year: 2017
A comparison of three different methods for analysing airway resistance in healthy subjects, asthma and chronic obstructive pulmonary disease patients
Source: Eur Respir J 2007; 30: Suppl. 51, 177s
Year: 2007
Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
Genomic variability of
haemophilus
in patients with COPD
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006
Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Clinical endotypes of exacerbation are associated with differences in microbial composition and diversity in COPD
Source: Eur Respir J, 56 (4) 2000391; 10.1183/13993003.00391-2020
Year: 2020
The pulmonary microbiome and immunological activity in IPF patients.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
Variation of microbiota in COPD patients during exacerbation and posterior stabilization: molecular characterization by metagenomic.
Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept